Autopsy report · NCT02724631

TubeClear® Evaluation in Pediatric Patients (Phase I)

“Unable to recruit; study determined not feasible to continue”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months before it started.
• Ran for about 3 years 8 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 4 years 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Children's Hospital of Philadelphia

Sponsor type

University, hospital or other

Conditions

Enteral Nutrition

Interventions

TubeClear® intervention

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Effects of Statin Therapy on Vascular Properties and Outcomes in Diastolic Heart Failure Patients
  “Unable to recruit into the study” (87% match in meaning)
• A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal
  “Unable to meet the study's recruitment goals” (83% match in meaning)
• Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I
  “Recruitment in study could not be reached after 8 yrs of recruiting” (81% match in meaning)
• Evaluation of the Versamed iVent in the Transport of Patients Receiving Mechanical Ventilation
  “Unable to recruit adequately” (80% match in meaning)
• Infantile Colic: Study of the Efficacy of Lactobacillus GG (ATCC 53103) Plus Chamomile in Breastfeeding Infants
  “Unable to recruit study participants” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.